Integra Healthcare

FUTURE OF HEALTHCARE

Ensemble Health Partners | December 15, 2021

Ensemble Health Partners, in partnership with Caduceus Capital Partners, led the $8 million Series A capital raise for Janus Health, a revenue cycle automation and decision support platform. Billions of dollars are left uncollected annually by healthcare providers due to poor methods and inconsistent human decision making in the revenue cycle process. Janus Health studies end-user behavior within the revenue cycle and uses advanced AI to determine the optimal path for ea...

PR Newswire | July 07, 2020

Building on its extensive background treating the impacts of PTSD and trauma with military veterans, and the experience of offering mental health resources to frontline healthcare providers and first responders in New York City, Cohen Veterans Network (CVN) is now offering free services in six additional locations of great need, as coronavirus cases surge again putting more stress on hospitals and first responders.CVN Frontline, a no-cost mental health resource center featuring interactive...

HEALTH TECHNOLOGY

Lyniate and MedAllies | August 22, 2022

Lyniate, a global leader in healthcare data interoperability, announced MedAllies, a leading multimodality connectivity services company, has chosen Lyniate Enterprise Master Patient Index (EMPI) by NextGate to better serve its healthcare clients and partners. This integration will bolster MedAllies’ identity data management capabilities to increase the accuracy of the data it exchanges for the benefit of all. As the healthcare industry continues to shift toward a more c...

MedCity News | January 15, 2020

Although it faced a setback earlier this month when regulators put the kibosh on its deal to acquire a rival company, genetic sequencing equipment maker Illumina will leave the J.P. Morgan Healthcare Conference with two new partnering deals under its belt. The San Diego-based company and Swiss drug and diagnostics maker Roche said Monday that they had formed a partnership to increase availability of genomic testing to patients with cancers. The 15-year, non-exclusive partnership is meant to broa...